当前位置:首页 - 行情中心 - 海特生物(300683) - 财务分析 - 现金流量表

海特生物

(300683)

  

流通市值:55.32亿  总市值:59.32亿
流通股本:1.22亿   总股本:1.31亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金253,376,022.67118,255,513.66569,099,446.94420,698,142.9
  收到的税费返还131,844.0620,109.732,273,668.434,692,068.75
  收到其他与经营活动有关的现金9,604,969.815,872,748.92116,850,407.6896,890,130.39
  经营活动现金流入小计263,112,836.54124,148,372.31688,223,523.05522,280,342.04
  购买商品、接受劳务支付的现金79,396,886.3439,092,289.11199,996,912.6151,612,211.29
  支付给职工以及为职工支付的现金138,775,375.3983,310,135284,298,654.77214,704,859.25
  支付的各项税费15,883,844.757,923,047.0130,158,529.0320,350,985.62
  支付其他与经营活动有关的现金87,129,414.7243,615,703.38151,083,584.94107,871,226.42
  经营活动现金流出小计321,185,521.2173,941,174.5665,537,681.34494,539,282.58
  经营活动产生的现金流量净额-58,072,684.66-49,792,802.1922,685,841.7127,741,059.46
二、投资活动产生的现金流量:
  收回投资收到的现金469,927,870.64200,006,237.011,854,360,0001,037,483,176.17
  取得投资收益收到的现金3,616,716.38910,971.5218,197,341.213,950,096.01
  处置固定资产、无形资产和其他长期资产收回的现金净额49,000-16,884.3415,000
  收到的其他与投资活动有关的现金--1,000,000-
  投资活动现金流入小计473,593,587.02200,917,208.531,873,574,225.541,051,448,272.18
  购建固定资产、无形资产和其他长期资产支付的现金29,731,962.9913,473,392.6643,080,104.9729,462,676.58
  投资支付的现金531,184,452.46375,729,677.911,924,445,710.51,049,730,502.1
  支付其他与投资活动有关的现金185,536.49-6,393,695-
  投资活动现金流出小计561,101,951.94389,203,070.571,973,919,510.471,079,193,178.68
  投资活动产生的现金流量净额-87,508,364.92-188,285,862.04-100,345,284.93-27,744,906.5
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,000,000-6,852,500-
  其中:子公司吸收少数股东投资收到的现金--6,852,500-
  筹资活动现金流入平衡项目0-0-
  筹资活动现金流入小计4,000,000-6,852,500-
  偿还债务支付的现金3,254,618.662,296,894.8314,600,00010,950,000
  分配股利、利润或偿付利息支付的现金17,436,607.3917,310,828.161,761,277.591,393,372.37
  支付其他与筹资活动有关的现金1,306,636.33692,2883,919,770.652,813,997
  筹资活动现金流出小计21,997,862.3820,300,010.9920,281,048.2415,157,369.37
  筹资活动产生的现金流量净额-17,997,862.38-20,300,010.99-13,428,548.24-15,157,369.37
四、汇率变动对现金及现金等价物的影响737.53-43,309.67-7.87
五、现金及现金等价物净增加额-163,578,174.43-258,378,675.22-91,044,681.79-15,161,224.28
  加:期初现金及现金等价物余额419,120,360.56419,120,360.56510,165,042.35510,165,042.35
  期末现金及现金等价物余额255,542,186.13160,741,685.34419,120,360.56495,003,818.07
补充资料:
  净利润-40,202,379.5--73,769,864.46-
  资产减值准备6,804,040.36-28,632,712.08-
  固定资产和投资性房地产折旧31,349,225.57-61,834,938.18-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧31,349,225.57-61,834,938.18-
  无形资产摊销11,859,259.14-26,185,239.45-
  长期待摊费用摊销1,923,408.32-4,094,052.22-
  处置固定资产、无形资产和其他长期资产的损失572.48-65,217.91-
  固定资产报废损失69,202.92-1,146,767.3-
  公允价值变动损失-5,136,870.6-908,853.74-
  财务费用748,297.18-2,317,055.6-
  投资损失-12,692,210.67--16,698,740.87-
  递延所得税-1,780,670.71--12,210,277.16-
  其中:递延所得税资产减少-1,567,778.62--10,467,513.68-
    递延所得税负债增加-212,892.09--1,742,763.48-
  存货的减少7,259,266.72--1,531,635.99-
  经营性应收项目的减少-5,508,690.91--51,755,278.32-
  经营性应付项目的增加-54,639,432.6-49,205,634.92-
  现金的期末余额255,542,186.13-419,120,360.56-
  减:现金的期初余额419,120,360.56-510,165,042.35-
  现金及现金等价物的净增加额-163,578,174.43--91,044,681.79-
公告日期2025-08-262025-04-212025-04-212024-10-23
审计意见(境内)标准无保留意见
TOP↑